The Journal of Immunology, Vol 157, Issue 10 4458-4463, Copyright © 1996 by American Association of Immunologists

ARTICLES

Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer

EL Klotz and U Storb
Committee on Immunology, University of Chicago, IL 60637, USA.

Previous experiments have suggested an important role for the Ig enhancers and transcription in targeting somatic hypermutation. To determine whether the requirement of the enhancers is Ig chain specific, we analyzed two lambda 2 light chain transgenes under the control of different enhancers, either the lambda 2-4 enhancer or the heavy chain intron enhancer. The transgenes were amplified and cloned from B220+PNAhigh B cells from either Peyer's patches (PP) or SRBC- immunized spleen. The lambda 2 transgene under the control of the lambda 2-4 enhancer underwent mutation in both the PP and splenic B cell populations, but at a frequency lower than endogenous light chain genes. This requirement for the lambda 2-4 enhancer could be replaced by the heavy chain intron enhancer. Interestingly, the heavy chain intron enhancer-driven lambda 2 construct showed evidence of statistically significant mutation in the PP B cell population, but not the spleen-derived population. This difference in somatic hypermutation suggests that a lower mutation frequency can be more readily detected in B220+PNAhigh B cells isolated from the PP. The ability of the heavy chain intron enhancer to replace the lambda 2-4 enhancer shows that the requirement for the Ig enhancers in somatic hypermutation is not Ig locus specific. Given that these Ig enhancers have very few elements in common, our results further suggest that the Ig enhancers are primarily important in the timing of transcription in the mutating B cell population.

This article has been cited by other articles:

				Y.-W. Chen, X.-T. Hu, A. C. Liang, W.-Y. Au, C.-C. So, M. L. Wong, L. Shen, Q. Tao, K.-M. Chu, Y.-L. Kwong, et al. High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma Blood, October 1, 2006; 108(7): 2373 - 2383. [Abstract] [Full Text] [PDF]

				M. A. Inlay, H. H. Gao, V. H. Odegard, T. Lin, D. G. Schatz, and Y. Xu Roles of the Ig {kappa} Light Chain Intronic and 3' Enhancers in Igk Somatic Hypermutation J. Immunol., July 15, 2006; 177(2): 1146 - 1151. [Abstract] [Full Text] [PDF]

				A. Terauchi, K. Hayashi, D. Kitamura, Y. Kozono, N. Motoyama, and T. Azuma A Pivotal Role for DNase I-Sensitive Regions 3b and/or 4 in the Induction of Somatic Hypermutation of IgH Genes J. Immunol., July 15, 2001; 167(2): 811 - 820. [Abstract] [Full Text] [PDF]

				J. Bachl, C. Carlson, V. Gray-Schopfer, M. Dessing, and C. Olsson Increased Transcription Levels Induce Higher Mutation Rates in a Hypermutating Cell Line J. Immunol., April 15, 2001; 166(8): 5051 - 5057. [Abstract] [Full Text] [PDF]

				H. Zan, A. Cerutti, P. Dramitinos, A. Schaffer, Z. Li, and P. Casali Induction of Ig Somatic Hypermutation and Class Switching in a Human Monoclonal IgM+ IgD+ B Cell Line In Vitro: Definition of the Requirements and Modalities of Hypermutation J. Immunol., March 15, 1999; 162(6): 3437 - 3447. [Abstract] [Full Text] [PDF]

				E. L. Klotz, J. Hackett Jr., and U. Storb Somatic Hypermutation of an Artificial Test Substrate Within an Ig{kappa} Transgene J. Immunol., July 15, 1998; 161(2): 782 - 790. [Abstract] [Full Text] [PDF]

				Q. Kong, L. Zhao, S. Subbaiah, and N. Maizels A {lambda} 3' Enhancer Drives Active and Untemplated Somatic Hypermutation of a {lambda}1 Transgene J. Immunol., July 1, 1998; 161(1): 294 - 301. [Abstract] [Full Text] [PDF]

				H. M. Shen, A. Peters, B. Baron, X. Zhu, and U. Storb Mutation of BCL-6 Gene in Normal B Cells by the Process of Somatic Hypermutation of Ig Genes Science, June 12, 1998; 280(5370): 1750 - 1752. [Abstract] [Full Text]

				H.-P. Brezinschek, S. J. Foster, T. Dorner, R. I. Brezinschek, and P. E. Lipsky Pairing of Variable Heavy and Variable {kappa} Chains in Individual Naive and Memory B Cells J. Immunol., May 15, 1998; 160(10): 4762 - 4767. [Abstract] [Full Text] [PDF]

				F. C. Kuo and J. Sklar Augmented Expression of a Human Gene for 8-oxoguanine DNA Glycosylase (MutM) in B Lymphocytes of the Dark Zone in Lymph Node Germinal Centers J. Exp. Med., November 3, 1997; 186(9): 1547 - 1556. [Abstract] [Full Text] [PDF]